Cefodizime: pharmacological characteristics and potential for clinical use in lower respiratory tract infections

Abstract

Cefodizime is a third–generation cephalosporin for parenteral use that has become available for the first time in the Russia. This paper reviews the use of this antibiotic in clinical practice based on the current data on antimicrobial resistance in pathogens causing lower respiratory tract infections and the results of completed clinical studies of its efficacy and safety.

Keywords

• cefodizime
• cephalosporins
• community-acquired pneumonia
• chronic obstructive pulmonary disease
• lower respiratory tract infections
• pneumococci
• antimicrobial resistance